Naltrexone
Opioid Antagonist | Low-Dose Anti-Inflammatory & Immune Modulation
Naltrexone is an opioid receptor antagonist originally developed and FDA-approved at full dose (50 mg) for the treatment of opioid and alcohol use disorders. At this dose, it competitively blocks mu-opioid receptors, preventing the euphoric and reinforcing effects of opioids and reducing alcohol cravings. However, naltrexone has gained enormous popularity in the biohacking and functional medicine communities at dramatically lower doses (1-4.5 mg), commonly referred to as Low-Dose Naltrexone (LDN). At these sub-therapeutic doses, naltrexone produces a brief, transient blockade of opioid receptors lasting only a few hours, which triggers a compensatory upregulation of endogenous endorphins and enkephalins. This rebound effect, combined with direct modulation of the Opioid Growth Factor (OGF) - OGF receptor axis, produces broad anti-inflammatory and immunomodulatory effects that have shown promise across a wide range of autoimmune, inflammatory, and chronic pain conditions.
Moleküler Gösterim
M.W.: 341.40 Da
PubChem 2D yapı diyagramı
Referans Flakon
Referans illüstrasyonu — ürün listesi değildir
Etki Mekanizması
At low doses (1-4.5 mg), naltrexone produces a brief nocturnal blockade of opioid receptors that lasts approximately 4-6 hours. This transient blockade triggers a compensatory upregulation of endogenous opioid production, including beta-endorphin and met-enkephalin (also known as Opioid Growth Factor, OGF). Elevated OGF interacts with the OGF receptor (OGFr) to modulate cell proliferation and immune function. LDN also directly antagonizes Toll-like receptor 4 (TLR4) on microglia and macrophages, reducing neuroinflammation and systemic inflammatory cytokine production including TNF-alpha, IL-6, and IL-12. The net effect is a shift from a pro-inflammatory Th1/Th17-dominant immune profile toward a more balanced regulatory state. Additionally, LDN has been shown to increase circulating endorphin levels by 200-300%, which contributes to improved mood, reduced pain perception, and enhanced immune surveillance. The bedtime dosing strategy is deliberate: the brief receptor blockade occurs during the natural nocturnal endorphin surge, maximizing the compensatory rebound effect.
Naltrexone is an opioid receptor antagonist originally developed and FDA-approved at full dose (50 mg) for the treatment of opioid and alcohol use disorders. At this dose, it competitively blocks mu-opioid receptors, preventing the euphoric and reinforcing effects of opioids and reducing alcohol cravings. However, naltrexone has gained enormous popularity in the biohacking and functional medicine communities at dramatically lower doses (1-4.5 mg), commonly referred to as Low-Dose Naltrexone (LDN). At these sub-therapeutic doses, naltrexone produces a brief, transient blockade of opioid receptors lasting only a few hours, which triggers a compensatory upregulation of endogenous endorphins and enkephalins. This rebound effect, combined with direct modulation of the Opioid Growth Factor (OGF) - OGF receptor axis, produces broad anti-inflammatory and immunomodulatory effects that have shown promise across a wide range of autoimmune, inflammatory, and chronic pain conditions.
Moleküler Veri
Araştırma Endikasyonları
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 40 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 43 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
moderateMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 42 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 42 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
effectiveMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 42 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 41 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
moderateMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 41 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 38 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 40 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
effectiveMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 40 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 39 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
moderateMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 39 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 39 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
moderateMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 38 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 37 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 38 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
moderateMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 37 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Doz Protokolleri
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 37 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
| Hedef | Doz | Sıklık | Yol |
|---|---|---|---|
| MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 36 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | 1.5 mg, titrate to 4.5 mg | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 53 MINUTES 01 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 11 HOURS 02 MINUTES 18 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE |
| MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 36 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | 0.5-1.0 mg, titrate slowly to 4.5 mg | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 53 MINUTES 01 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 11 HOURS 02 MINUTES 18 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE |
| MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 36 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | 50 mg/day | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 11 HOURS 04 MINUTES 45 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 11 HOURS 02 MINUTES 18 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE |
| MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 36 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | 50 mg/day | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 11 HOURS 04 MINUTES 45 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE | MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 11 HOURS 02 MINUTES 18 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE |
Etkileşimler
Opioid Medications
compatibleMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 36 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Phenibut
monitorMYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 35 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Ne Beklenmeli
Yan Etkiler & Güvenlik
Yaygın Yan Etkiler
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 35 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 35 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 34 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 34 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Durdurma Belirtileri
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 34 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 33 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 33 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 33 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Kontrendikasyonlar
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 32 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 32 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 32 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
- •MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 31 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Saklama:MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 59 MINUTES 21 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Sık Sorulan Sorular
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 31 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 30 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 30 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 30 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 29 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 29 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 29 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
MYMEMORY WARNING: YOU USED ALL AVAILABLE FREE TRANSLATIONS FOR TODAY. NEXT AVAILABLE IN 10 HOURS 36 MINUTES 28 SECONDS VISIT HTTPS://MYMEMORY.TRANSLATED.NET/DOC/USAGELIMITS.PHP TO TRANSLATE MORE
Kaynaklar
- Low-dose naltrexone (LDN) - Review of therapeutic utilization — Younger, J., Parkitny, L., McLain, D.
- Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels — Younger, J., Noor, N., McCue, R., Mackey, S.
- Low-dose naltrexone therapy improves active Crohn's disease — Smith, J.P., Stock, H., Bingaman, S., et al.
- The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain — Younger, J., Mackey, S.
- Opioid Growth Factor and Low-Dose Naltrexone: A Comprehensive Review — McLaughlin, P.J., Zagon, I.S.